Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2007
07/12/2007WO2007076601A1 Imaging of d2high receptors using radiolabelled (-)- quinpirole and analogs thereof
07/12/2007WO2007059257A8 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
07/12/2007WO2007048070A3 Pyrrolo-pyridine derivatives for the treatment of cancer diseases
07/12/2007WO2007042321A3 Kinase inhibitors
07/12/2007WO2007038459A3 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
07/12/2007WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof
07/12/2007WO2007030775A3 Amide and carbamate derivatives of n-{2-[4-amino-2- (ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
07/12/2007WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists
07/12/2007WO2007027780A3 Benzopyran and pyranopyridine derivatives as potassium channel openers
07/12/2007WO2007026218A3 Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
07/12/2007WO2007019100A3 Hiv integrase inhibitors
07/12/2007WO2007019098A3 Hiv integrase inhibitors
07/12/2007WO2007002308A3 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
07/12/2007WO2007001385B1 Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
07/12/2007WO2006107478A3 Crystalline sodium salt of an hiv integrase inhibitor
07/12/2007WO2006093514A3 Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines
07/12/2007WO2006009718A3 Methods for treating or preventing erectile dysfunction or urinary incontinence
07/12/2007US20070161673 P38 kinase inhibitors
07/12/2007US20070161671 7-Azaindoles and the use thereof as therapeutic agents
07/12/2007US20070161670 Process for the preparation of substituted heterocycles
07/12/2007US20070161668 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
07/12/2007US20070161653 Pyrazolo-Pyridine Derivatives As Antiherpes Agents
07/12/2007US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS
07/12/2007US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders
07/12/2007US20070161640 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
07/12/2007US20070161639 Hiv integrase inhibitors
07/12/2007US20070161635 Kinase inhibitors
07/12/2007US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
07/12/2007US20070161630 Tricyclic tetrahydroquinoline antibacterial agents
07/12/2007US20070161627 Antibacterial agents
07/12/2007US20070161624 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
07/12/2007US20070161622 Diamino alcohols and their use as renin inhibitor
07/12/2007US20070161621 Spiroazacyclic compounds as monoamine receptor modulators
07/12/2007US20070161619 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
07/12/2007US20070157398 Novel naphthalene derivatives and colorants for keratin fibers containing these compounds
07/12/2007CA2636264A1 Bicyclic heteroaryl compounds as pde10 inhibitors
07/12/2007CA2635850A1 Heterocyclic janus kinase 3 inhibitors
07/12/2007CA2635846A1 Trisazo compound, ink composition, recording method, and colored article
07/12/2007CA2635802A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
07/12/2007CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
07/12/2007CA2634320A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them
07/12/2007CA2634120A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives
07/12/2007CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors
07/12/2007CA2629148A1 Pdf inhibitors
07/11/2007EP1806348A2 Pyrido (2,3-D)Pyrimidines as inhibitors of cellular proliferation
07/11/2007EP1806347A1 Aromatic-ring-fused pyrimidine derivative
07/11/2007EP1805179A2 Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
07/11/2007EP1805178A2 Process for preparing 4,5-dihydro-pyrazolo [3,4-c]pyrid-2-ones
07/11/2007EP1805177A1 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof
07/11/2007EP1805176A2 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
07/11/2007EP1805175A1 Novel azaindole thiazolinones as anti-cancer agents
07/11/2007EP1805174A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity
07/11/2007EP1805173A2 7, 8, 9, 10- tetrahydro-imidazo [2,1-a] isoquinoline derivatives and their use as gastric acid secretion inhibitors
07/11/2007EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
07/11/2007EP1805144A1 Heterocyclical chromophore architectures
07/11/2007EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease
07/11/2007EP1804919A2 Cgrp receptor antagonists
07/11/2007EP1804797A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
07/11/2007EP1804791A1 Tetrahydro pyridinyl pyrazole cannabinoid modulators
07/11/2007EP1660495B1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
07/11/2007EP1572657B1 Processes for preparing quinolonecarboxylate derivatives
07/11/2007EP1497287A4 Quinolinone derivatives
07/11/2007EP1248784B1 Condensed azepines as vasopressin agonists
07/11/2007EP1175398B1 Indoline derivatives as progesterone antagonists
07/11/2007EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents
07/11/2007CN1997643A Heterocyclic compounds and their use as aldosterone synthase inhibitors
07/11/2007CN1997642A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
07/11/2007CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
07/11/2007CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/11/2007CN1995037A Preparation method of chiral proton pump inhibitor
07/11/2007CN1994301A Heterocyclic compounds which are active as inhibitors of beta lactamases
07/11/2007CN1325497C Pharmaceutically active isoindoline derivs.
07/11/2007CN1325496C Preparation process of sophora alopecuroides series alkaloid salts substances
07/11/2007CN1325495C Preparation process of sophoridine
07/11/2007CN1325494C 3-substituted nalidixic acid analog compound and its preparation method and uses in pharmacy
07/11/2007CN1325480C Novel phenylalanine derivatives
07/11/2007CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors
07/11/2007CN1325379C Synthesis of ITQ-17 in the absence of fluoride ions
07/10/2007US7241892 Hemisynthetic method and new compounds
07/10/2007US7241789 Substituted indoles and their use as integrin antagonists
07/10/2007US7241788 Cannabinoid receptor ligands and uses thereof
07/10/2007US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
07/10/2007US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
07/10/2007US7241772 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity
07/10/2007US7241770 Hydronopol derivatives as agonists on human ORL1 receptors
07/10/2007US7241767 And thiones, 1-substituted with a pyrazolyl(thio)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops
07/10/2007US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
07/10/2007US7241759 Cholecystokinin receptors as modulators to mediate diseases and gastrointestinal disorders
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/05/2007WO2007076348A2 Azaindole inhibitors of aurora kinases
07/05/2007WO2007076127A2 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
07/05/2007WO2007076086A2 Tricyclic spiro compounds useful as transforming growth factor modulators
07/05/2007WO2007076035A2 Anti-viral compounds
07/05/2007WO2007076034A2 Anti-viral compounds
07/05/2007WO2007075946A1 Compounds useful in cftr assays and methods therewith
07/05/2007WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
07/05/2007WO2007074491A1 HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
07/05/2007WO2007074137A1 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
07/05/2007WO2007074089A1 Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives
07/05/2007WO2007058392A9 Heterocyclic compound and medicinal application thereof